Guideline Central’s Post

The six dimensions of The ASAM Criteria were updated in the Fourth Edition. The Third Edition’s Dimension 4: Readiness to Change does not contribute independently to the recommended level of care; rather, it impacts clinical judgments related to risks in other dimensions and influences the services that should be delivered at any level of care and should be carefully considered in treatment planning. The Fourth Edition reorders the dimensions such that consideration of readiness to change is integrated across dimensions and replaced by a new dimension, Dimension 6: Person-Centered Considerations. This new dimension considers barriers to care—including social determinants of health (SDOH)—patient preferences, and the need for motivational enhancement. The Fourth Edition also simplifies and updates dimension names to reflect the field’s evolving terminology and facilitate effective dissemination of these standards. American Society of Addiction Medicine - ASAM

Don't miss out on the opportunity to join psychiatrist Dr. Robert Tanguay for an insightful live webinar! Mark your calendars for Thursday, April 18, 2024, from 7:00 pm to 8:00 pm as Dr. Tanguay delves into the topic of using the dissociative anaesthetic ketamine in psychiatric disorders.   During this session, Dr. Tanguay will provide a comprehensive review of the evidence supporting the use of ketamine for psychiatric disorders. He'll explore various theories on its mechanism of action and shed light on who stands to benefit the most from ketamine therapy.   CCCEP accreditation pending. Learn more at https://lnkd.in/e5nr4YE   #ABPharmacists #RxALearn #pharmacy #professionaldevelopment #healthcare

MultiCare’s Healthy Behavior and Function Clinic offers a unique approach to medication-assisted treatment for substance use disorder (SUD) with a low-barrier clinic setting, unlike any other in the region. According to Dr. Lora Jasman, MD, FACP, an internal and addiction medicine provider at MultiCare Rockwood Clinic, this approach is crucial for SUD treatment as access can be lifesaving. Dr. Jasman, who has been with the clinic since its establishment six years ago, emphasizes their distinctive philosophy of 'no wrong door,' providing immediate care to those in need. Learn more about their compassionate approach to SUD treatment: [Link to article] #SUD #healthcare #addictionmedicine #multicare

Meet Dr. Kathryn A. Cunningham, Director of the UTMB Health Center for Addiction Sciences and Therapeutics at The University of Texas Medical Branch. Substance use disorders (SUDs) pose a significant challenge, as they often damage brain function related to motivation and decision-making. While psychedelics like psilocybin have shown promise in helping with recovery, their risks—such as hallucinations and safety concerns—make them challenging to use widely. Dr. Cunningham is working on a solution that focuses on developing new compounds that similarly boost brain function but without harmful side effects. This approach could open up new, safer treatment options for those struggling with cocaine and stimulant addiction, areas where no approved medications currently exist. Welcome to #I4SUD2024, Dr. Cunningham! #AddictionRecovery #MentalHealthInnovation #SubstanceUseDisorder #HealthcareSolutions #SUDTreatment

Substance use disorders and psychiatric disorders frequently co-occur, and it is often difficult to differentiate independent from secondary disorders in patients. PCSS-MOUD: Educate, Train, Mentor, led by AAAP with a coalition of over 17 national professional healthcare organizations, is equipping providers with the education and training needed to address the opioid and substance use epidemic. Every day, physicians, nurse practitioners, and PAs are gaining the tools needed to adequately provide the treatment and care their patients deserve, including those with comorbidities. Visit pcssnow.org to access modules, webinars, podcasts, videos, clinical tools, and other resources designed to enhance provider knowledge and skills in evidence-based treatment practices. For more insights like the one seen in this image, check out “The Top Ten Things Every Physician Should Know About Addiction,” a guide developed in collaboration with AAAP, the American Psychiatric Association, the American Academy of Family Physicians, and the American Society of Addiction Medicine - ASAM: https://bit.ly/3NCa00F  #AmericanAcademyofAddictionPsychiatry #TreatmentWeek #NATW #AddictionTreatment #TreatAddictionSaveLives 

Patients Receiving Psychiatric Care May Be at Increased Risk of Pandemic-Related Stress, But Are Not at Increased Risk of Believing in Conspiracy Theories: Experts emphasize the importance of awareness when using social media and make suggestions on how to combat the spread of misinformation and conspiracy theories. #finance #pharmacy #lifesciences

Is TMS NeuroStar right for you? TMS therapy is a new alternative depression treatment. NeuroStar TMS Therapy is a proven, non-drug therapy for depression and it is a depression treatment provided at Psychiatric Care Center in Redding. Learn about TMS treatment at PCC: https://lnkd.in/gk3u6dCM #depressionhelp #depressiontreatment #neurostartms

What is the key to operating a successful psychiatric practice offering ketamine infusion therapy? Here are my thoughts.

Addiction Medicine Grand Rounds: SAMHSA’s Final Rule on Methadone: Implications for Implementation, Patient Outcomes, and Future Directions March 26, 2024 — 12PM to 1:30PM ET 📍 REGISTRATION: https://lnkd.in/g4kV9_Nv The Yale Program in Addiction Medicine is pleased to welcome hold a special session of Addiction Medicine Grand Rounds on March 26th, 2024, 12:00-1:30pm, with invited panelists detailed below. This event will be held virtually via Zoom and extend a half hour longer than our typical sessions. Topic: SAMHSA’s Final Rule on Methadone: Implications for Implementation, Patient Outcomes, and Future Directions Learning objectives: ☑️ Describe key regulatory changes introduced by SAMHSA’s Final Rule on Methadone. ☑️ Consider mechanisms of enforcement, monitoring, and evaluation during implementation of regulatory changes in methadone treatment settings. ☑️ Discuss implications of changes in methadone regulation for treatment facilities, healthcare providers, and patients receiving methadone. Addiction Medicine Grand Rounds are CME accredited. Each session will be assigned 1 AMA PRA Category 1 CreditsTM. #Methadone #ProfessionalDevelopment

“Treatment plan, and Treatment plan’s engagement plan”. Over years, psychiatric treatment settings appear more inclined towards symptom focused therapy, with strong treatment plans taking a backseat. A comprehensive and early treatment plan is foremost in chronic psychiatric condition management, with stakeholder involvement pivotal in treatment success. Moreover, a cogent treatment plan requires a superimposed treatment plan’s engagement plan. The engagement plan needs continuous steering to keep the treatment plan on improvement pathway relative to medical and social aspects of centered individual.